ஆரோக்கியமான வயதான ஆராய்ச்சி
திறந்த அணுகல்

சுருக்கம்

Post-Reproductive Health. Opportunity Window For The Prevention Of Co Morbidities

Victor Manuel Vargas Hernandez

Menopausal hormone therapy (THM) is fraught with controversy, and post-reproductive health is quite challenging. It has gone through many years of ups and downs. We recognize that comorbidity is more common after menopause, and we must need preventive measures to avoid it. When THM was used uniformly, the risk-benefit ratio became unfavorable, and its usage plummeted; nevertheless, more recent studies also introduced the idea of a “window of opportunity,” in which THM has no negative side effects and actually prevents comorbidities associated with menopause.